DTIL Stock Analysis: Buy, Sell, or Hold?
DTIL - Precision BioSciences, Inc. Common Stock
$8.59
-0.17 (-1.94%)
▼
5d:
+4.25%
30d:
+33.18%
90d:
+28.79%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When DTIL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: DTIL is 10.7% above its trading range ($7.76). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: DTIL is 10.7% above its trading range ($7.76). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: DTIL is currently trading at $8.59, which is considered extended relative to its 30-day fair value range of $6.20 to $7.76.
Technical Outlook: Technically, DTIL is in a strong uptrend. The price is approaching resistance at $8.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DTIL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.60 (+244.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DTIL is in a strong uptrend. The price is approaching resistance at $8.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DTIL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.60 (+244.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.20 -
$7.76
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+10.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 244.6% below Wall St target ($29.60)
Trading Range Analysis
30-Day Trading Range
$6.20 -
$7.76
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.00
Resistance Level
$8.22
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.54
Wall Street Target
$29.60
(+244.6%)
Revenue Growth (YoY)
37272.4%
Profit Margin
-96.7%
Share & Embed Analysis
Last updated: July 13, 2026 10:33 PM ET
Data refreshes hourly during market hours. Next update: 11:33 PM
Data refreshes hourly during market hours. Next update: 11:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DTIL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
J. Jefferson Smith
SELL
4925 shares
2026-02-18
John Alexander Kelly
SELL
8149 shares
2026-02-18
Michael Amoroso
SELL
20559 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
